Ethyl 3-bromo-7-methylpyrazolo[1,5-a]pyrimidine-6-carboxylate
≥95%
- Product Code: 184688
CAS:
1370287-43-6
Molecular Weight: | 284.11 g./mol | Molecular Formula: | C₁₀H₁₀BrN₃O₂ |
---|---|---|---|
EC Number: | MDL Number: | MFCD22377539 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective modification, making it valuable in medicinal chemistry for optimizing drug potency and bioavailability. Commonly employed in research settings to design compounds targeting inflammatory diseases and certain neurological disorders due to its ability to cross biological membranes and interact with specific enzyme active sites.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | €399.79 |
+
-
|
250mg | 10-20 days | €639.66 |
+
-
|
1g | 10-20 days | €1,665.44 |
+
-
|
Ethyl 3-bromo-7-methylpyrazolo[1,5-a]pyrimidine-6-carboxylate
Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective modification, making it valuable in medicinal chemistry for optimizing drug potency and bioavailability. Commonly employed in research settings to design compounds targeting inflammatory diseases and certain neurological disorders due to its ability to cross biological membranes and interact with specific enzyme active sites.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :